Prof. Dr. Meinrad Beer, Director of the Clinic for Diagnostic and Interventional Radiology, University Hospital Ulm

Prof. Meinrad Beer

mint Lesion™ has become an indispensable part of our tumor boards and clinical trials. It significantly strengthens the recognition of radiology and the cooperation between imaging departments and with clinical partners.

Related Resources

Related Resources

A radiologist reviewing the updated PCWG4 prostate cancer clinical trial guidelines.

From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials

The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…

Group photo of Mint Medical and mediaire team

Mint Medical and mediaire strengthen the prostate cancer care pathway with AI-Powered MRI Solutions

Mint Medical, a Snke company, and mediaire announce a collaboration to advance AI‑powered MRI workflows through the interoperability of mint Lesion…

ECR 2026

03/04 to 03/07/2026 Vienna, Austria

European Congress of Radiology